Skip to content

Clinical trials

Phase 2 Pulmonary Arterial Hypertension trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Arterial Hypertension Phase: Phase 2 Clear all

116 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20051
20065
20073
20082
20095
20107
20118
20125
20134
20144
20152
20165
20175
20188
201913
20203
20214
20225
20237
20243
20257
20268

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed58
Terminated26
Recruiting12
Not yet recruiting7
Withdrawn6
Unknown status5
Active, not recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Actelion6
Novartis Pharmaceuticals5
United Therapeutics5
Bastiaan Driehuys4
GlaxoSmithKline4
Lung Biotechnology PBC4
Merck Sharp & Dohme LLC4
University of Pennsylvania4
Gilead Sciences3
Imperial College London3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Arterial Hypertension116
Hypertension, Pulmonary38
Familial Primary Pulmonary Hypertension9
Lung Diseases, Interstitial5
Connective Tissue Diseases4
Idiopathic Pulmonary Fibrosis4
Lung Diseases4
Cardiovascular Diseases3
Hypertension3
Vascular Diseases3

Trials

Showing 76 to 100 of 116. Each trial links to its page on Pharma Observatory.

16 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.